Target intelligence / Profile preview

Hyaluronan mediated motility receptor (RHAMM)

Target
RHAMM
Molecular classification
Receptor, Cargo receptor, Hyaladherin (hyaluronan-binding protein)
01

Overview

The Hyaluronan mediated motility receptor (RHAMM; also known as HMMR or IHABP) is a cell surface and intracellular protein that binds to hyaluronan—a major component of the extracellular matrix. It plays a critical role in regulating cell motility, migration, and proliferation. When hyaluronan binds to RHAMM, it triggers phosphorylation events involving proteins such as PTK2/FAK1 and can activate the ERK signaling pathway. This receptor is implicated in processes like inflammation, wound healing, tissue remodeling, and especially cancer progression by promoting cellular transformation and metastasis formation. Multiple isoforms exist due to alternative splicing; some are associated with aggressive tumor phenotypes when localized in the nucleus or on the cell surface. The primary endogenous ligand for this target is hyaluronic acid itself[4][1].

Other names
RHAMMHMMRIHABPIntracellular hyaluronic acid-binding proteinReceptor for hyaluronan-mediated motility
02

Mechanism of action

Binding of hyaluronan to RHAMM activates intracellular signaling pathways such as phosphorylation of PTK2/FAK1 and ERK pathway, influencing cell migration and proliferation

03

Biological functions

Cell motility and migrationRegulation of cell proliferationInvolvement in cellular transformation and metastasis formationRegulation of extracellular-regulated kinase (ERK) activity
04

Disease associations

Cancer (especially breast cancer)Inflammation
05

Interacting drugs

Hyaluronic acid (acts as a ligand/binder)

Beyond the preview

Go deeper on Hyaluronan mediated motility receptor (RHAMM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hyaluronan mediated motility receptor (RHAMM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call